ALB and osteosarcoma: Results from trials based on inhibition of recruitment and depletion of TAMs have been disappointing, so the focus seems to be changing toward reprogramming.7 The drug MDP was one of the earliest immunotherapies used in dogs.31,57 MDP had a significant clinical benefit in dogs with osteosarcoma and HSA compared with those treated with surgery alone.